Patent · US Active

Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)

US11479564B2 · kind B2 · utility

1Cited by

15References

7Claims

0Family size

Assignee

Valo Health, Inc. · US

Inventors

Kenneth W. Bair · Chapel Hill, US
Timm R. Baumeister · Watertown, US
Alexandre Joseph Buckmelter · Superior, US
Karl H. Clodfelter · Watertown, US
Bingsong Han · Westwood, US
Judith D. Kuntz · Watertown, US
Jian Lin · Watertown, US
Dominic Reynolds · Stoneham, US
Chase C. Smith · Rutland, US
Zhongguo Wang · Lexington, US
Xiaozhang Zheng · Lexington, US

Key dates

Filing date	Sep 16, 2020
Grant date	Oct 25, 2022
Priority date	—
Expiry date	Sep 16, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below: Formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.